EUVIMEDEUVIMED entdecken
Open Access

Humoral responses to SARS-CoV-2 vaccine in vasculitis-related immune suppression

Kimia Kamelian iD, Benjamin Sievers iD, Michael Chen-Xu, Sam Turner, Mark Tsz Kin Cheng iD, Mazharul Altaf iD, Steven A Kemp iD, Adam Abdullahi iD, Kata Csiba, Dami A Collier iD, Petra Mlcochova, Bo Meng und 8 weitere

Science Advances · 14.02.2025 · 11 (7)

DOI: 10.1126/sciadv.adq3342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 14.02.2025. Verfasst von Kimia Kamelian und 19 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Department of Medicine, University of Cambridge, Cambridge, Cambridgeshire, UK. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19 Vaccines, COVID-19, Immunity, Humoral. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune suppression poses a challenge to vaccine immunogenicity. We show that serum antibody neutralization against SARS-CoV-2 Omicron descendants was largely absent post-doses 1 and 2 in individuals with vasculitis treated with rituximab. Detectable and increasing neutralizing titers were observed post-doses 3 and 4, except for XBB. Rituximab in vasculitis exacerbates neutralization deficits over standard immunosuppressive therapy, although impairment resolves over time since dosing. We observed discordance between detectable IgG binding and neutralizing activity specifically in the context of rituximab use, with high proportions of individuals showing reasonable IgG titer but no neutralization. ADCC response was more frequently detectable compared to neutralization in the context of rituximab, indicating that a notable proportion of binding antibodies are non-neutralizing. Therefore, use of rituximab is associated with severe impairment in neutralization against Omicron descendants despite repeated vaccinations, with better preservation of non-neutralizing antibody activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19 VaccinesCOVID-19Immunity, HumoralVasculitisHumansAntibodies, NeutralizingAntibodies, ViralMiddle AgedMaleFemaleImmunoglobulin GRituximabAgedAdultImmunosuppressive Agents

Substanzen

Antibodies, NeutralizingCOVID-19 VaccinesAntibodies, ViralImmunoglobulin GRituximabImmunosuppressive Agents

Autor:innen und Institutionen

  • School of Clinical Medicine, Department of Medicine, University of Cambridge, Cambridge, Cambridgeshire, UK.
  • Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Cambridge, Cambridgeshire, UK.
  • Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, Cambridgeshire, UK.
  • Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, UK.
  • Department of Renal Medicine, Addenbrooke's Hospital, Cambridge, Cambridgeshire, UK.
  • The Walter and Eliza Hall Institute of Medical Research (WEHI), Parkville, VIC 3052, Australia.

ORCID-Profile: Kimia Kamelian, Benjamin Sievers, Mark Tsz Kin Cheng, Mazharul Altaf, Steven A Kemp, Adam Abdullahi, Dami A Collier, Rachel B Jones, Derek Smith, John Bradley, Kenneth G C Smith, Rainer Doffinger, Ravindra K Gupta

Förderung

  • Wellcome Trust

Zitieren

APA

Kamelian, K., Sievers, B., Chen-Xu, M., Turner, S., Cheng, M. T. K., Altaf, M., Kemp, S. A., Abdullahi, A., Csiba, K., Collier, D. A., Mlcochova, P., Meng, B., Jones, R. B., CITIID-NIHR BioResource COVID-19 Collaboration, Smith, D., Bradley, J., Smith, K. G. C., Doffinger, R., Smith, R. M., & Gupta, R. K. (2025). Humoral responses to SARS-CoV-2 vaccine in vasculitis-related immune suppression. Science Advances, 11(7). https://doi.org/10.1126/sciadv.adq3342

Vancouver

Kamelian K, Sievers B, Chen-Xu M, Turner S, Cheng MTK, Altaf M, et al. Humoral responses to SARS-CoV-2 vaccine in vasculitis-related immune suppression. Science Advances. 2025;11(7). doi:10.1126/sciadv.adq3342

BibTeX
@article{Kamelian2025,
  author = {Kamelian, Kimia and Sievers, Benjamin and Chen-Xu, Michael and Turner, Sam and Cheng, Mark Tsz Kin and Altaf, Mazharul and Kemp, Steven A and Abdullahi, Adam and Csiba, Kata and Collier, Dami A and Mlcochova, Petra and Meng, Bo and Jones, Rachel B and CITIID-NIHR BioResource COVID-19 Collaboration, CITIID-NIHR BioResource COVID-19 Collaboration and Smith, Derek and Bradley, John and Smith, Kenneth G C and Doffinger, Rainer and Smith, Rona M and Gupta, Ravindra K},
  title = {Humoral responses to SARS-CoV-2 vaccine in vasculitis-related immune suppression},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {7},
  doi = {10.1126/sciadv.adq3342}
}
Kostenlos starten →